CATALYST FINANCIAL PARTNERS LLC

Position in PFE — Pfizer Inc

CIK 1927537 BOSTON, MA

Position in PFE

as of Jun 30, 2026 · filed Jul 30, 2026 Compact

Position Value

$605,612

-$50,898 QoQ

Shares Held

25,150

+7.6% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.12%

of 13F equity value

Holder Rank

#1,627

of 2,821 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

CATALYST FINANCIAL PARTNERS LLC holds $23,806,391 across 9 Drug Manufacturers - General names. PFE ranks #7 (2.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	6,449	$7,735,124
2	JNJ	Johnson & Johnson	24,867	$6,315,471
3	ABBV	AbbVie Inc.	15,393	$3,873,494
4	MRK	Merck & Co., Inc.	20,205	$2,596,342
5	AMGN	Amgen Inc	3,386	$1,226,138
6	GILD	Gilead Sciences, Inc.	5,716	$722,159
7	PFE	Pfizer Inc This page	25,150	$605,612
8	BMY	Bristol Myers Squibb Co	8,894	$512,472

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$605,612	25,150	+7.6%	Shares	Sole	2026-07-30
2026-03-31	$656,510	23,380	+16.6%	Shares	Sole	2026-05-12
2025-12-31	$499,319	20,053	+11.9%	Shares	Sole	2026-02-04
2025-09-30	$456,652	17,922	+6.1%	Shares	Sole	2025-11-12
2025-06-30	$409,559	16,896	-15.0%	Shares	Sole	2025-08-14
2025-03-31	$503,607	19,874	+13.5%	Shares	Sole	2025-05-02
2024-12-31	$464,699	17,516	-19.7%	Shares	Sole	2025-01-30
2024-09-30	$631,383	21,817	+22.5%	Shares	Sole	2024-10-28
2024-06-30	$498,491	17,816	+31.1%	Shares	Sole	2024-07-25
2024-03-31	$376,983	13,585	+6.5%	Shares	Sole	2024-04-23
2023-12-31	$367,274	12,757	-25.7%	Shares	Sole	2024-02-07
2023-09-30	$569,528	17,170	-26.3%	Shares	Sole	2023-10-26
2023-06-30	$854,313	23,291	+21.7%	Shares	Sole	2023-08-02
2023-03-31	$780,544	19,131	+43.7%	Shares	Sole	2023-04-11
2022-12-31	$682,260	13,315	—	Shares	Sole	2023-01-19
No filing history on record for this holder in this stock.